---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-101605"
form_type: "8-K"
ticker: "BRKR"
cik: "0001109354"
company_name: "BRUKER CORP"
filed_at: "2025-08-04T23:59:59+00:00"
generated_at: "2026-05-17T21:21:33.589769+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Bruker Q2 revenue $797M, -0.4% YoY; non-GAAP EPS $0.32, -38.5%; lowers FY2025 guidance

## Summary
- Q2 revenue $797.4M, organic -7.0% YoY from weak US academic and biopharma demand.
- GAAP EPS $0.05; non-GAAP EPS $0.32, down 38.5% vs Q2 2024 $0.52.
- BSI segment revenue $733.2M (organic -7.2%); BEST segment $66.3M (organic -4.8%).
- FY2025 guidance cut: revenue $3.43-3.50B (2-4% reported growth), non-GAAP EPS $1.95-2.05 vs FY2024 $2.41.
- Announced expanded cost initiative targeting $100-120M annual savings in FY2026.

## SEC filing metadata
- accession: 0000950170-25-101605
- form_type: 8-K
- ticker: BRKR
- cik: 0001109354
- company_name: BRUKER CORP
- filed_at: 2025-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1109354/000095017025101605/0000950170-25-101605-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1109354/000095017025101605/brkr-20250804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-101605
- JSON: https://secwatch.observer/filing/0000950170-25-101605.json
- Plain text: https://secwatch.observer/filing/0000950170-25-101605.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.